The global topical wound agents market size is expected to reach USD 2.2 billion by 2026, expanding at a CAGR of 9.4%, according to a new report by Grand View Research, Inc. The rising prevalence of chronic injuries, growing number of surgical procedures, launch of technologically advanced products, and increasing cases of burns globally are the key driving factors for the market.
Topical
wound agents generally provide adequate moisture to the bruise and allow
autolytic debridement. The increasing prevalence of chronic injuries and rising
number of surgical procedures are the key driving factors for market growth.
For instance, as per a report published by the ScienceDirect in 2018, surgical
infection has highest prevalence rate of around 4.0%, followed by diabetic foot
ulcers which are around 3.4%. In addition, rising number of medical facilities
for treating unhealed bruises across the globe is also expected to surge market
growth over the forecast period. In May 2019, Dalvkot Wound Care (DWC)
established the first medical facility for treating bruises in Bangalore,
India, which aims to provide remedies to chronic injuries. Thus, such
developments may boost the demand for topical wound agents, as they are
specifically used for such conditions. Furthermore, new product launches by key
players may also positively impact market growth. For instance, Arch
Therapeutics, Inc., launched AC5 Topical Gel, which got its FDA approval in
October 2019. This gel allows rapid injury healing with minimal risk of getting
further complications. Therefore, such factors are anticipated to propel growth
of the market over the forecast period.
Full Research Report On Topical Wound Agents Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/topical-wound-agents-market
Topical Wound
Agents Market Report Highlights
- In terms of revenue, the
acute wounds segment held the largest share in 2018 owing to rising cases
of burn and surgical bruises across the globe
- The creams segment held the
largest market share and is expected to witness fastest growth rate over
the forecast period owing to increasing incidence of diabetic and venous
leg ulcers across the globe
- The hospital segment held
the largest share in 2018 due to rising cases of road accidents worldwide
- The Asia Pacific topical
wound agents market is expected to witness the fastest growth over the
forecast period owing to rising number of diabetic patients in this region
- Prominent players present in
the market are Smith & Nephew PLC.; Teva Pharmaceuticals USA, Inc.;
and Mölnlycke Health Care AB.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/topical-wound-agents-market/request/rs1
Topical Wound
Agents Market Segmentation
Grand View Research has segmented
the global topical wound agents market based on product, application, end use,
and region:
Topical Wound
Agents Product Outlook (Revenue, USD Million, 2015 - 2026)
- Creams
- Gels
- Sprays
- Others
Topical Wound
Agents Application Outlook (Revenue, USD Million, 2015 - 2026)
- Chronic Wounds
- Diabetic Foot Ulcers
- Pressure Ulcers
- Venous Leg Ulcers
- Others
- Acute Wounds
- Surgical & Traumatic
- Burns
Topical Wound
Agents End-use Outlook (Revenue, USD Million, 2015 - 2026)
- Hospitals
- Clinics
- Others
Topical Wound
Agents Regional Outlook (Revenue, USD Million, 2015 - 2026)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Asia-Pacific
- Japan
- China
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
- Saudi Arabia
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment